Breast Cancer
Advertisement
The study explored outcomes of CBT and how it can help reduce disease burden for female patients with breast cancer.
TROPiCS-02 study data shows that sacituzumab govitecan improves overall survival for HR+/HER2- metastatic breast cancer.
Patients with metastatic breast cancer experienced reduced fatigue interference with functioning with the addition of ACT.
Learn how a team developed a predictive model for breast cancer using cfDNA low-pass whole genome sequencing.
The study analyzed quality-adjusted time without symptoms of disease progression or toxicity of treatment, known as Q-TWiST.
A randomized study is evaluating a nurse-led educational intervention on physical activity for patients with breast cancer.
Learn what the study showed about shorter courses of post-mastectomy radiation combined with breast reconstruction.
Sacituzumab govitecan is associated with better QoL benefit than TPC in patients with HR+/HER2− BC.
An exploratory study focused on understanding dietary patterns and adherence to recommended nutritional guidelines.
Researchers explored the relationship between post-traumatic growth and perceived stress in this population of patients.
Less than half of patients with cancer had caregivers who spoke for more than 4% of a clinical encounter.
Learn how a personalized 12-week exercise program can enhance quality of life outcomes in survivors of breast cancer.
Empowerment-Based Nursing Intervention Improved Patient Outlook After Breast Cancer Brain Metastases
Researchers analyzed if the intervention could improve negative emotions, quality of life, and satisfaction with nursing. 
A new study highlights the effectiveness of a nurse navigation program for patients undergoing treatment for these cancers.
Researchers aimed to identify the best timing for telenursing follow-up after chemotherapy.
There are several important nursing considerations to keep in mind when evaluating a patient’s risk for breast cancer.
Panelists discuss data from the ADEPT trial, port considerations, and their hopes for the future of breast cancer therapy.
Panelists discuss how nurses can maximize opportunities for connection as they treat patients with breast cancer.
The panelists discuss clinical trial data and patient preferences surrounding subcutaneous versus IV administration routes.
Panelists discuss how subcutaneous treatments can mitigate time toxicity and improve quality of life.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.